Determinants of failure to access care in mothers referred to HIV treatment programs in Nairobi, Kenya.
BACKGROUND
As prevention of mother-to-child transmission of HIV (PMTCT) programs and HIV treatment programs rapidly expand in parallel, it is important to determine factors that influence the transition of HIV-infected women from maternal to continuing care.


METHODS
This study aimed to determine rates and co-factors of accessing HIV care by HIV-infected women exiting maternal care. A cross-sectional survey of women who had participated in a PMTCT research study and were referred to care programs in Nairobi, Kenya was conducted.


METHODS
A median of 17 months following referral, women were located by peer counselors and interviewed to determine whether they accessed HIV care and what influenced their care decisions. Fisher's exact test was used to assess the association between client characteristics and access to care.


RESULTS
Peer counselors traced 195 (82%) residences, where they located 116 (59%) participants who provided information on care. Since exit, 50% of participants had changed residence, and 74% reported going to the referral HIV program. Reasons for not accessing care included lack of money, confidentiality, and dislike of the facility. Women who did not access care were less likely to have informed their partner of the referral (p=0.001), and were less likely believe that highly active antiretroviral therapy (HAART) is effective (p<0.01). Among those who accessed care, 33% subsequently discontinued care, most because they did not qualify for HAART. Factors cited as barriers to access included stigma, denial, poor services, and lack of money. Factors that were cited as making care attractive included health education, counseling, free services, and compassion.


CONCLUSIONS
A substantial number of women exiting maternal care do not transit to HIV care programs. Partner involvement, a standardized referral process and more comprehensive HIV education for mothers diagnosed with HIV during pregnancy may facilitate successful transitions between PMTCT and HIV care programs.
Otieno
Phelgona A
PA
Centre for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Kohler
Pamela K
PK
Bosire
Rose K
RK
Brown
Elizabeth R
ER
Macharia
Steven W
SW
John-Stewart
Grace C
GC
D000328:Adult; D003430:Cross-Sectional Studies; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D007630:Kenya; D008427:Maternal Health Services; D009035:Mothers / Q000523:psychology*; D010342:Patient Acceptance of Health Care; D055815:Young Adult
N Engl J Med. 2009 Apr 30;360(18):1815-26
19339714
Lancet. 2008 Mar 1;371(9614):752-9
18313504
Curationis. 2007 Jun;30(2):12-23
17703819
Trop Med Int Health. 2005 Dec;10(12):1242-50
16359404
Arch Gynecol Obstet. 2009 Nov;280(5):745-52
19242706
Lancet. 2002 Jul 13;360(9327):119-29
12126821
J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):500-5
18197117
AIDS. 2003 Jan 3;17(1):65-71
12478070
J Acquir Immune Defic Syndr. 2004 Jan 1;35(1):75-81
14707796
J Infect Dis. 2007 Jan 15;195(2):220-9
17191167
JAMA. 2001 Nov 28;286(20):2568-77
11722271
Trans R Soc Trop Med Hyg. 2008 Nov;102(11):1067-74
18565559
AIDS. 2005 Jul 1;19(10):1035-42
15958834
AIDS Care. 2007 Apr;19(4):487-91
17453588